T N Zabotina - JoVE Visualize

Showing results (1-10 of 24) with videos related to

Pageof 3

Sort By:

Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|June 30, 2010

[Hydrophilic regulator hexapeptides as inhibitors of tumor cell multiple drug resistance]V V Lebedev, S A Novikov, E Iu Rybalkina, et al.

Urologiia I Nefrologiia|November 1, 1995

[Effect of the spread of the process and treatment on the phenotype of peripheral blood lymphocytes in patients with prostatic cancer]A V Ivshina, Zh D Zhumagazin, T N Zabotina, et al.

Bulletin of Experimental Biology and Medicine|January 24, 2012

Comparative analysis of cells with combined apoptosis and proliferation markers in thyroid tissue specimens from patients with cancer, adenoma, and autoimmune diseasesS P Kazakov, T N Zabotina, O V Korotkova, et al.

Arkhiv Patologii|November 27, 2023

[Molecular mechanisms of impaired antigenic presentation as a cause of tumor escape from immune surveillance]A A Korotaeva, A A Borunova, A Yu Kuzevanova, et al.

Biulleten' Eksperimental'Noi Biologii I Meditsiny|June 1, 1989

[ICO-45 monoclonal antibodies to the new epitope of antigen CD38]A Iu Baryshnikov, T N Zabotina, I V Dubinkin, et al.

Membrane & Cell Biology|June 15, 1999

Coordinated regulation of P-glycoprotein activity and cytochrome P-4501A induction in sublines of rat hepatoma McA RH7777 cells with different levels of colchicine resistanceE L Gujaeva, V A Kobliakov, T N Zabotina, et al.

Bulletin of Experimental Biology and Medicine|November 1, 2006

Variations in the number of regulatory T cells (CD4+CD25+) in patients with breast cancer during herceptin therapyE G Slavina, A I Chertkova, T N Zabotina, et al.

Biokhimiia (Moscow, Russia)|April 1, 1995

[Modulation of the level of sphingomyelin cycle products and expression of the CD3 receptor in immunocompetent organs by fumonisin B1]E A Martynova, A S Solov'ev, A V Khrenov, et al.

Voprosy Onkologii|January 1, 1992

[The lymphocyte immunological phenotype of young and middle-aged breast cancer patients]N S Chobanian, V P Letiagin, E V Savel'eva, et al.

British Journal of Cancer|July 17, 1998

Influence of exogenous RAR alpha gene on MDR1 expression and P-glycoprotein function in human and rodent cell linesT P Stromskaya, E Y Rybalkina, A A Shtil, et al.

Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:

Pageof 3

Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|June 30, 2010

[Hydrophilic regulator hexapeptides as inhibitors of tumor cell multiple drug resistance]V V Lebedev, S A Novikov, E Iu Rybalkina, et al.

Urologiia I Nefrologiia|November 1, 1995

[Effect of the spread of the process and treatment on the phenotype of peripheral blood lymphocytes in patients with prostatic cancer]A V Ivshina, Zh D Zhumagazin, T N Zabotina, et al.

Bulletin of Experimental Biology and Medicine|January 24, 2012

Comparative analysis of cells with combined apoptosis and proliferation markers in thyroid tissue specimens from patients with cancer, adenoma, and autoimmune diseasesS P Kazakov, T N Zabotina, O V Korotkova, et al.

Arkhiv Patologii|November 27, 2023

[Molecular mechanisms of impaired antigenic presentation as a cause of tumor escape from immune surveillance]A A Korotaeva, A A Borunova, A Yu Kuzevanova, et al.

Biulleten' Eksperimental'Noi Biologii I Meditsiny|June 1, 1989

[ICO-45 monoclonal antibodies to the new epitope of antigen CD38]A Iu Baryshnikov, T N Zabotina, I V Dubinkin, et al.

Membrane & Cell Biology|June 15, 1999

Coordinated regulation of P-glycoprotein activity and cytochrome P-4501A induction in sublines of rat hepatoma McA RH7777 cells with different levels of colchicine resistanceE L Gujaeva, V A Kobliakov, T N Zabotina, et al.

Bulletin of Experimental Biology and Medicine|November 1, 2006

Variations in the number of regulatory T cells (CD4+CD25+) in patients with breast cancer during herceptin therapyE G Slavina, A I Chertkova, T N Zabotina, et al.

Biokhimiia (Moscow, Russia)|April 1, 1995

[Modulation of the level of sphingomyelin cycle products and expression of the CD3 receptor in immunocompetent organs by fumonisin B1]E A Martynova, A S Solov'ev, A V Khrenov, et al.

Voprosy Onkologii|January 1, 1992

[The lymphocyte immunological phenotype of young and middle-aged breast cancer patients]N S Chobanian, V P Letiagin, E V Savel'eva, et al.

British Journal of Cancer|July 17, 1998

Influence of exogenous RAR alpha gene on MDR1 expression and P-glycoprotein function in human and rodent cell linesT P Stromskaya, E Y Rybalkina, A A Shtil, et al.

Pageof 3